Ocugen Inc (OCGN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.87
• Market Cap: $608.82M
• EPS: $-0.22
• 52-Week High: $1.96
• 52-Week Low: $0.52

Market Sentiment

Ocugen Inc currently has a Bullish sentiment score of 0.25.

About Ocugen Inc

Ocugen, Inc. is an innovative clinical-stage biopharmaceutical company focused on developing transformative gene therapies aimed at curing various forms of blindness. Based in Malvern, Pennsylvania, the company leverages its proprietary technologies and strategic partnerships to advance its therapeutic pipeline, which includes treatments for retinal diseases. With a commitment to addressing unmet medical needs in ocular health, Ocugen is poised to make significant contributions to the field o...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Ocugen Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does OCGN pay dividends?

Ocugen Inc (OCGN) does not currently pay a regular dividend.

What is OCGN's market cap?

Ocugen Inc (OCGN) has a market capitalization of $608.82M with a current stock price of $1.87.